Larmarco acts as a crusader against “corrupt” companies which in this instance his “research” appears to be the only “flop”. How on earth Culper Research has any credibility is beyond me. I’d say some restrictions are coming his way for the baseless comments.
NEU’s answer was a professional reply. I can’t see how they could have done more. Culper Research don’t understand norms in the medical world in regards to retention rates and what makes up statistics. NEU look strong by not engaging directly or saying more IMO. Dust will settle quickly and we will all actually forget about it.
Onwards and Up!
Ann: Comment on research report, page-130
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |